Autosomal Dominant Polycystic Kidney Disease clinical trials at UCSD
1 research study open to eligible people
open to eligible people ages 18-60
The goal of the study is to compare and evaluate safety and efficacy of tesevatinib 50mg versus placebo in patients with ADPKD.
La Jolla, California and other locations